Invention Grant
- Patent Title: Derivatisation of erythropoietin (EPO)
- Patent Title (中): 促红细胞生成素（EPO）的衍生化
-
Application No.: US13646605Application Date: 2012-10-05
-
Publication No.: US08796207B2Publication Date: 2014-08-05
- Inventor: Gregory Gregoriadis , Sanjay Jain , Peter Laing , Norbert Oskar Rumpf
- Applicant: Lipoxen Technologies Limited
- Applicant Address: GB London
- Assignee: Lipoxen Technologies Limited
- Current Assignee: Lipoxen Technologies Limited
- Current Assignee Address: GB London
- Agency: One3 IP Management P.C.
- Priority: EP06117830 20060725
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/00 ; C07K1/00
Abstract:
The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and comprises between 2 and 200 saccharide units. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.
Public/Granted literature
- US20130116176A1 DERIVATISATION OF ERYTHROPOIETIN (EPO) Public/Granted day:2013-05-09
Information query
IPC分类:
